Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Small-molecule dual alphavbeta3/alphavbeta5 integrin inhibitor Sch-221153 inhibits angiogenesis

May 2, 2001

Novogen creates new company to develop phenoxodiol

May 2, 2001

LEraf-AON, a liposomal antisense oligodeoxyribonucleotide for enhancing radiation effects

May 2, 2001

Myriad Genetics' MPC-7869 stabilizes PSA levels in phase II

May 2, 2001

Lilly claims new use of parathyroid hormone

April 30, 2001

IntaBiotics' Protegrin IB-367 rinse meets secondary but not primary endpoints

April 30, 2001

MX-2060: a novel caspase-activating apoptosis inducer discovered at Maxim

April 30, 2001

Aventis prepares oxindoles as potent inhibitors of cyclin-dependent kinases

April 30, 2001

PhotoCure seeks marketing approval for Metvix(R) PDT in New Zealand

April 30, 2001

Indena focuses on modulators of MDR

April 27, 2001

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
Japan endorses two iPSC drugs for approval under CEA pathway
BioWorld
Japan is backing conditional approvals of Amchepry (raguneprocel, Sumitomo Pharma Co. Ltd./Racthera Co. Ltd.) and Reheart (Cuorips Inc.), positioning them to...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...